Retinitis Pigmentosa (RP)

Phase I/II Open-Label Trial of UGX202 for Advanced Retinitis Pigmentosa

Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy (SPVN20) in Subjects With Rod-Cone Dystrophy

Study to Evaluate the Long-Term Safety of Ultevursen in Participants With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

Safety Evaluation Study of Pitavastatin PLGA Nano-particle for Retinitis Pigmentosa

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration

A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment

24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome

Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases

Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases

Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance

Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients

Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection)

Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital

UGX202 Injection in Patients With Advanced Retinitis Pigmentosa

Wide Field OCTA in Ocular Diseases

Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations

Subthreshold Micropulse Laser Therapy (SML) in Retinitis Pigmentosa